Skip to main content
Top
Published in: Abdominal Radiology 1/2022

01-01-2022 | Esophagography | Hollow Organ GI

Same day barium esophagography and high-resolution manometry during the COVID-19 pandemic

Authors: Stephanie D. Colvin, Jessica G. Zarzour, Desiree E. Morgan, James P. Callaway, Britney L. Corey, Jayleen Grams, Samuel J. Galgano

Published in: Abdominal Radiology | Issue 1/2022

Login to get access

Abstract

Purpose

Double contrast barium esophagography (BAS) and high-resolution manometry (HRM) are traditionally performed on separate days to allow for pre-procedural fasting. In an effort to minimize COVID-19 exposure and improve appointment efficiency with required pre-procedure testing, we permitted same day HRM prior to BAS. Our study aimed to evaluate the adequacy of barium mucosal coating with same day HRM prior to BAS compared to BAS alone.

Methods

We performed a retrospective pilot cohort study including 14 patients undergoing same day HRM prior to BAS and 20 patients undergoing BAS alone over an 8-month interval during the COVID-19 pandemic. Three abdominal imaging subspecialty-trained radiologists blindly reviewed the images and graded adequacy of esophageal coating on a 4-point scale with a score of 1 representing inadequate coating and 4 representing optimal coating.

Results

For the cohort studied thus far, the mean grade of the HRM and BAS group was 3.17 with a standard deviation of 0.66. The mean grade of the BAS alone group was 3.13 with a standard deviation of 0.79. There was no statistical difference in the adequacy of esophageal coating between the two groups (p-value 0.97).

Conclusion

Same day HRM prior to BAS has no detrimental effect on barium mucosal coating compared to BAS alone. Though created to limit patient exposures during the COVID pandemic, same day BAS and HRM may prevent delays in care and improve convenience towards improved patient-centered care beyond the pandemic.

Graphic abstract

Literature
2.
go back to reference Rubin EB, ME; Thomas, L; Torres, WE. ACR Practice Parameter for the Performance of Esophagrams and Upper Gastrointestinal Examinations in Adults American College of Radiology. Rubin EB, ME; Thomas, L; Torres, WE. ACR Practice Parameter for the Performance of Esophagrams and Upper Gastrointestinal Examinations in Adults American College of Radiology.
18.
go back to reference Gruner M, Denis A, Masliah C, et al. Narrow-band imaging versus Lugol chromoendoscopy for esophageal squamous cell cancer screening in normal endoscopic practice: randomized controlled trial. Endoscopy. Jul 22 2020;https://doi.org/10.1055/a-1224-6822 Gruner M, Denis A, Masliah C, et al. Narrow-band imaging versus Lugol chromoendoscopy for esophageal squamous cell cancer screening in normal endoscopic practice: randomized controlled trial. Endoscopy. Jul 22 2020;https://​doi.​org/​10.​1055/​a-1224-6822
Metadata
Title
Same day barium esophagography and high-resolution manometry during the COVID-19 pandemic
Authors
Stephanie D. Colvin
Jessica G. Zarzour
Desiree E. Morgan
James P. Callaway
Britney L. Corey
Jayleen Grams
Samuel J. Galgano
Publication date
01-01-2022
Publisher
Springer US
Published in
Abdominal Radiology / Issue 1/2022
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-021-03322-2

Other articles of this Issue 1/2022

Abdominal Radiology 1/2022 Go to the issue

Editorial

2021 update

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.